Zimmer Biomet Holdings, Inc.
ZBHNYSEHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $19.05B
- P/E (TTM)
- 23.61
- Forward P/E
- 24.54
- Dividend yield
- 0.97%
- 52-week range
- $79.12$106.88
- Volume (live)
- -
- Avg. volume (3M)
- 2.04M
Zimmer Biomet Holdings (ZBH) Stock Price & Financial Analysis
Zimmer Biomet Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $95.43 - $98.92 |
|---|---|
| 52-Week High | $106.88 |
| 52-Week Low | $79.12 |
| Open | $95.96 |
| Volume (last close) | 2.22M |
| Average Volume (3M) | 2.04M |
| Revenue (TTM) | 8.51B |
|---|---|
| Net Income (TTM) | 806.80M |
| Free Cash Flow (TTM) | 1.54B |
| EPS (TTM) | $4.11 |
| Profit Margin | 9.48% |
| Operating Margin | 16.40% |
| Return on Equity (ROE) | 6.39% |
| Debt to Equity | 0.59 |
| Annual Dividend | $0.96 |
|---|---|
| Dividend Yield | 0.97% |
| Payout Ratio | 23.37% |
| Last Dividend Ex-Date | Sep 30, 2026 |
| Market Cap | 19.05B |
|---|---|
| Shares Outstanding | 192.80M |
| P/E Ratio (TTM) | 23.61 |
| Forward P/E | 24.54 |
| Price to Sales (P/S) | 2.24 |
| Price to Book (P/B) | 1.51 |
| EV/EBITDA | 10.91 |
| 50-Day MA | $95.21 |
|---|---|
| 200-Day MA | $91.44 |
| 1-Year Change | −4.22% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Zimmer Biomet Holdings at a Glance
As of the Oct 22, 2026 close, Zimmer Biomet Holdings (ZBH) has a market capitalization of $19.05B. The stock trades at 23.6× trailing earnings, 24.5× forward earnings and 2.2× sales. Over the trailing twelve months it earned $806.80M on revenue of $8.51B (a 9.5% profit margin) and generated $1.54B of free cash flow. Revenue grew 8.6% year over year.
As of its latest reported balance sheet, it holds $410.00M in cash and securities against $7.48B of debt, a net debt position of $7.07B.
Zimmer Biomet Holdings pays a quarterly dividend totaling $0.96 per share a year, a 0.97% yield at the Oct 22, 2026 close, with a 23% payout ratio.
The share price is down 4.2% over the past year. At $98.81 (the Oct 22, 2026 close) it sits within its 52-week range of $79.12 to $106.88, above its 200-day moving average of $91.44.
Based on 21 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $104.88, 6.1% above the Oct 22, 2026 close.
Frequently Asked Questions About Zimmer Biomet Holdings
What is the current stock price for ZBH?
As of the Oct 22, 2026 close, ZBH stock trades at $98.81. The 52-week range is $79.12–$106.88, with a day range of $95.43–$98.92.
What is the P/E ratio for ZBH?
As of the Oct 22, 2026 close, Zimmer Biomet Holdings's trailing twelve-month (TTM) P/E ratio is 23.6, meaning investors pay $23.6 for every $1 of annual earnings. The forward P/E is 24.5, reflecting analyst expectations for future earnings. Zimmer Biomet Holdings operates in the Healthcare sector.
Does ZBH pay dividends?
Yes, Zimmer Biomet Holdings pays a 0.97% annual dividend yield as of the Oct 22, 2026 close ($0.96 per share a year). The trailing twelve-month payout ratio is 23.4%. The most recent ex-dividend date was September 30, 2026.
What do analysts recommend for ZBH?
Based on ratings from 21 professional analysts over the last 90 days, the consensus for ZBH is Hold. The average 12-month price target is $104.88, a 6.1% upside from the Oct 22, 2026 close of $98.81.
What is the market cap of ZBH?
As of the Oct 22, 2026 close, Zimmer Biomet Holdings's market capitalization is $19.05B, classifying it as a large-cap company. Zimmer Biomet Holdings operates in the Healthcare sector within the Medical Devices industry.